| Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets J Tel, G Schreibelt, SP Sittig, TSM Mathan, SI Buschow, LJ Cruz, ... Blood, The Journal of the American Society of Hematology 121 (3), 459-467, 2013 | 224 | 2013 |
| Human plasmacytoid dendritic cells: from molecules to intercellular communication network TSM Mathan, CG Figdor, SI Buschow Frontiers in immunology 4, 372, 2013 | 123 | 2013 |
| Essential role for autophagy during invariant NKT cell development M Salio, DJ Puleston, TSM Mathan, D Shepherd, AJ Stranks, ... Proceedings of the National Academy of Sciences 111 (52), E5678-E5687, 2014 | 114 | 2014 |
| Human dendritic cell subsets undergo distinct metabolic reprogramming for immune response F Basit, T Mathan, D Sancho, IJM De Vries Frontiers in immunology 9, 412397, 2018 | 92 | 2018 |
| Proteomics of human dendritic cell subsets reveals subset-specific surface markers and differential inflammasome function K Worah, TSM Mathan, TPV Manh, S Keerthikumar, G Schreibelt, J Tel, ... Cell reports 16 (11), 2953-2966, 2016 | 76 | 2016 |
| Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen RN Tunjungputri, AJ Van Der Ven, A Schonsberg, TS Mathan, ... Aids 28 (14), 2091-2096, 2014 | 41 | 2014 |
| Human pDCs are superior to cDC2s in attracting cytolytic lymphocytes in melanoma patients receiving DC vaccination JJP van Beek, G Flórez-Grau, MAJ Gorris, TSM Mathan, G Schreibelt, ... Cell reports 30 (4), 1027-1038. e4, 2020 | 35 | 2020 |
| Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells AE Sköld, TSM Mathan, JJP van Beek, G Flórez-Grau, ... Cancer Immunology, Immunotherapy 67, 1425-1436, 2018 | 22 | 2018 |
| Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy TSM Mathan, J Textor, AE Sköld, I Reinieren-Beeren, T van Oorschot, ... Oncotarget 8 (12), 19879, 2017 | 18 | 2017 |
| Human pDCs are superior to cDC2s in attracting cytolytic immune effector cells in mel-anoma patients receiving DC vaccination JJP van Beek, G Flórez-Grau, MAJ Gorris, TSM Mathan, G Schreibelt, ... ORCHESTRATING THE IMMUNE RESPONSE, 145, 2019 | | 2019 |
| Innate (-like) lymphocytes in DC vaccination J van Beek, T Mathan, J Textor, J de Vries EUROPEAN JOURNAL OF IMMUNOLOGY 48, 31-32, 2018 | | 2018 |
| Beneath the surface-Resolving DC subset characteristics by using omics to improve DC immunotherapies TSM Mathan [Sl]:[Sn], 2018 | | 2018 |
| Reports (accepted 18/07/2016) available at K Worah, TS Mathan, TPV Manh, S Keerthikumar, G Schreibelt, J Tel, ... | | |
Carl G. FigdorprofVerified email at radboudumc.nl
